{"transactions":[{"id":4634428,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-10-03T00:15:43.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":32012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":32012,"derivative":{"exercise_price":1.18,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":32012},"source":{"system":"sec-edgar","filing":"0001878313-26-000096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000096/form4.xml","form_type":"4"}},{"id":4616607,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-14T13:03:34.000Z","date":"2026-09-10","kind":"purchase","planned":false,"acquired":true,"shares":37595,"price":1.3171,"value":49516.3745,"ownership":{"direct":true},"balance_after":773296,"source":{"system":"sec-edgar","filing":"0001878313-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1913253/000187831326000084/form4.xml","form_type":"4"}},{"id":671335,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-01T20:16:26.000Z","date":"2026-08-28","kind":"purchase","planned":false,"acquired":true,"shares":46620,"price":1.35,"value":62937.0,"ownership":{"direct":true},"balance_after":735701,"source":{"system":"sec-edgar","filing":"0001878313-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000082/form4.xml","form_type":"4"}},{"id":671334,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-01T20:16:26.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":78239,"price":1.39,"value":108752.21,"ownership":{"direct":true},"balance_after":689081,"source":{"system":"sec-edgar","filing":"0001878313-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000082/form4.xml","form_type":"4"}},{"id":671333,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-01T20:16:26.000Z","date":"2026-08-26","kind":"purchase","planned":false,"acquired":true,"shares":8931,"price":1.39,"value":12414.09,"ownership":{"direct":true},"balance_after":610842,"source":{"system":"sec-edgar","filing":"0001878313-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000082/form4.xml","form_type":"4"}},{"id":675163,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-26T11:56:42.000Z","date":"2026-08-24","kind":"purchase","planned":false,"acquired":true,"shares":1794,"price":1.33,"value":2386.02,"ownership":{"direct":true},"balance_after":601911,"source":{"system":"sec-edgar","filing":"0001878313-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000079/form4.xml","form_type":"4"}},{"id":677582,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-24T20:09:57.000Z","date":"2026-08-20","kind":"purchase","planned":false,"acquired":true,"shares":11899,"price":1.37,"value":16301.63,"ownership":{"direct":true},"balance_after":600117,"source":{"system":"sec-edgar","filing":"0001878313-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000077/form4.xml","form_type":"4"}},{"id":718390,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-07-02T20:14:09.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":26355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":26355,"derivative":{"exercise_price":1.44,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":26355},"source":{"system":"sec-edgar","filing":"0001878313-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000073/form4.xml","form_type":"4"}},{"id":819911,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-04-02T20:55:27.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":27258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":27258,"derivative":{"exercise_price":1.4,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":27258},"source":{"system":"sec-edgar","filing":"0001878313-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000037/form4.xml","form_type":"4"}},{"id":951968,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Options","published_at":"2026-01-05T13:38:10.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":24060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":24060,"derivative":{"exercise_price":1.53,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":24060},"source":{"system":"sec-edgar","filing":"0001878313-26-000010","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000010/form4.xml","form_type":"4"}},{"id":1023446,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-10-06T20:23:14.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":20459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20459,"derivative":{"exercise_price":1.8,"exercise_date":"2025-10-02","expiration_date":"2035-10-02","underlying":"Common Stock","underlying_shares":20459},"source":{"system":"sec-edgar","filing":"0001878313-25-000029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000029/form4.xml","form_type":"4"}},{"id":1095578,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-07-02T20:17:45.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":20380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20380,"derivative":{"exercise_price":1.8,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":20380},"source":{"system":"sec-edgar","filing":"0001127602-25-018658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225018658/form4.xml","form_type":"4"}},{"id":1152380,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-05-12T20:14:02.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.05,"value":41000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on May 8, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date."}],"balance_after":20000,"derivative":{"exercise_price":2.05,"exercise_date":"2026-05-08","expiration_date":"2031-05-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127602-25-013965","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225013965/form4.xml","form_type":"4"}},{"id":1152379,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-12T20:14:02.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.5,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on May 8, 2025."}],"balance_after":588218,"source":{"system":"sec-edgar","filing":"0001127602-25-013965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225013965/form4.xml","form_type":"4"}},{"id":1175727,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-04-08T20:45:58.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":20291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20291,"derivative":{"exercise_price":1.5,"exercise_date":"2025-04-04","expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":20291},"source":{"system":"sec-edgar","filing":"0001127602-25-011815","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225011815/form4.xml","form_type":"4"}},{"id":1222984,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-03-05T21:42:20.000Z","date":"2025-03-03","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":1.85,"value":61666.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on March 3, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date."}],"balance_after":33333,"derivative":{"exercise_price":1.85,"exercise_date":"2026-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001127602-25-008330","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008330/form4.xml","form_type":"4"}},{"id":1222983,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-05T21:42:20.000Z","date":"2025-03-03","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":1.5,"value":49999.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 3, 2025."}],"balance_after":568218,"source":{"system":"sec-edgar","filing":"0001127602-25-008330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008330/form4.xml","form_type":"4"}},{"id":1223024,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-03-05T21:37:22.000Z","date":"2025-02-24","kind":"purchase","planned":false,"acquired":true,"shares":73333,"price":1.87,"value":137132.71,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"This Form 4/A is being filed to correct the \"Date Exercisable\" and \"Expiration Date\" in Section 6 of Table II reported in the original Form 4 filed on February 25, 2025 as well as to correct the date of the Securities Purchase Agreement orginally referenced in the footnote 1 and 2 to \"February 24, 2025\"."},{"field":"shares","element":"transactionShares","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date."}],"balance_after":73333,"derivative":{"exercise_price":1.87,"exercise_date":"2026-02-25","expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":73333},"source":{"system":"sec-edgar","filing":"0001127602-25-008317","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008317/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-25"}},{"id":1223023,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-05T21:37:22.000Z","date":"2025-02-24","kind":"purchase","planned":false,"acquired":true,"shares":73333,"price":1.5,"value":109999.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plna on February 24, 2025."}],"balance_after":534885.04,"source":{"system":"sec-edgar","filing":"0001127602-25-008317","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008317/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-25"}},{"id":1246708,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-02-25T21:11:24.000Z","date":"2025-02-24","kind":"purchase","planned":false,"acquired":true,"shares":73333,"price":1.87,"value":137132.71,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2024.  The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date."}],"balance_after":73333,"derivative":{"exercise_price":1.87,"exercise_date":"2025-08-24","expiration_date":"2030-08-24","underlying":"Common Stock","underlying_shares":73333},"source":{"system":"sec-edgar","filing":"0001127602-25-006578","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225006578/form4.xml","form_type":"4"}},{"id":1246707,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-25T21:11:24.000Z","date":"2025-02-24","kind":"purchase","planned":false,"acquired":true,"shares":73333,"price":1.5,"value":109999.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were isused under the Issuer's 2021 Equity Incentive Plan on February 24, 2024."}],"balance_after":534885,"source":{"system":"sec-edgar","filing":"0001127602-25-006578","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225006578/form4.xml","form_type":"4"}},{"id":1315328,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-01-03T21:14:03.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":10225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":10225,"derivative":{"exercise_price":1.98,"exercise_date":"2024-12-31","expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":10225},"source":{"system":"sec-edgar","filing":"0001127602-25-000406","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225000406/form4.xml","form_type":"4"}},{"id":1332561,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Warrants","published_at":"2024-12-13T22:15:42.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":53418,"price":2.08,"value":111109.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on December 13, 2024.  The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date."}],"balance_after":53418,"derivative":{"exercise_price":2.08,"exercise_date":"2025-06-13","expiration_date":"2030-06-13","underlying":"Common Stock","underlying_shares":53418},"source":{"system":"sec-edgar","filing":"0001127602-24-029380","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224029380/form4.xml","form_type":"4"}},{"id":1332560,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-13T22:15:42.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":53418,"price":1.872,"value":99998.496,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 13, 2024."}],"balance_after":514970,"source":{"system":"sec-edgar","filing":"0001127602-24-029380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224029380/form4.xml","form_type":"4"}},{"id":1377269,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Warrants","published_at":"2024-11-04T21:36:18.000Z","date":"2024-11-01","kind":"purchase","planned":false,"acquired":true,"shares":88534,"price":2.259,"value":199998.306,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These warrants were purchased pursuant to a Securities Purchase Agreement dated and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024.  The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date."}],"balance_after":88534,"derivative":{"exercise_price":2.259,"exercise_date":"2025-05-01","expiration_date":"2030-05-01","underlying":"Common Stock","underlying_shares":88534},"source":{"system":"sec-edgar","filing":"0001127602-24-026380","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026380/form4.xml","form_type":"4"}},{"id":1377268,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-04T21:36:18.000Z","date":"2024-11-01","kind":"purchase","planned":false,"acquired":true,"shares":88534,"price":2.51,"value":222220.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024."}],"balance_after":408134.04,"source":{"system":"sec-edgar","filing":"0001127602-24-026380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026380/form4.xml","form_type":"4"}},{"id":1394764,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-10-02T20:52:15.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":7232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of thate date."}],"balance_after":7232,"derivative":{"exercise_price":2.81,"exercise_date":"2024-09-30","expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":7232},"source":{"system":"sec-edgar","filing":"0001127602-24-024949","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224024949/form4.xml","form_type":"4"}},{"id":1463436,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-07-02T20:14:36.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":5728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":5728,"derivative":{"exercise_price":3.42,"exercise_date":"2024-06-30","expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":5728},"source":{"system":"sec-edgar","filing":"0001127602-24-019865","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224019865/form4.xml","form_type":"4"}},{"id":1553962,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-04-02T20:56:23.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":9193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":9193,"derivative":{"exercise_price":2.2,"exercise_date":"2024-03-31","expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":9193},"source":{"system":"sec-edgar","filing":"0001127602-24-011887","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224011887/form4.xml","form_type":"4"}},{"id":1574972,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Warrants","published_at":"2024-03-15T23:04:21.000Z","date":"2024-03-14","kind":"purchase","planned":false,"acquired":true,"shares":6928,"price":1.3,"value":9006.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants were purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024.  The options are exercisable beginning on the six month anniverary of the issuance date and expire 5-years after the initial exercise date."}],"balance_after":6928,"derivative":{"exercise_price":1.3,"exercise_date":"2024-09-14","expiration_date":"2029-09-14","underlying":"Common Stock","underlying_shares":6928},"source":{"system":"sec-edgar","filing":"0001127602-24-010320","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224010320/form4.xml","form_type":"4"}},{"id":1574971,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-15T23:04:21.000Z","date":"2024-03-14","kind":"purchase","planned":false,"acquired":true,"shares":6928,"price":1.17,"value":8105.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024."}],"balance_after":319600.04,"source":{"system":"sec-edgar","filing":"0001127602-24-010320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224010320/form4.xml","form_type":"4"}},{"id":1693269,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-01-04T02:02:10.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":15418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":15418,"derivative":{"exercise_price":1.17,"exercise_date":"2023-12-31","expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":15418},"source":{"system":"sec-edgar","filing":"0001127602-24-000648","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224000648/form4.xml","form_type":"4"}},{"id":1767930,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-10-03T20:10:37.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":8378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":8378,"derivative":{"exercise_price":2.2,"exercise_date":"2023-09-30","expiration_date":"2033-09-30","underlying":"Common Stock","underlying_shares":8378},"source":{"system":"sec-edgar","filing":"0001127602-23-025151","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223025151/form4.xml","form_type":"4"}},{"id":1836813,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-07-05T12:17:49.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":8910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":8910,"derivative":{"exercise_price":2.2,"exercise_date":"2023-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":8910},"source":{"system":"sec-edgar","filing":"0001127602-23-019774","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223019774/form4.xml","form_type":"4"}},{"id":1882864,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-22T10:49:30.000Z","date":"2023-05-18","kind":"purchase","planned":true,"acquired":true,"shares":1200,"price":2.47,"value":2964.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $2.40 to $2.50, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":312672.04,"source":{"system":"sec-edgar","filing":"0001127602-23-016379","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223016379/form4.xml","form_type":"4"}},{"id":1911463,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-28T10:50:27.000Z","date":"2023-04-27","kind":"purchase","planned":false,"acquired":true,"shares":8500,"price":2.25,"value":19125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023."}],"balance_after":311472.04,"source":{"system":"sec-edgar","filing":"0001127602-23-013712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223013712/form4.xml","form_type":"4"}},{"id":1917324,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-19T10:55:30.000Z","date":"2023-04-18","kind":"purchase","planned":true,"acquired":true,"shares":1263,"price":4.17,"value":5266.71,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $4.01 to $4.25, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":302972.04,"source":{"system":"sec-edgar","filing":"0001127602-23-013177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223013177/form4.xml","form_type":"4"}},{"id":1928964,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-04-04T10:34:51.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":5675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":5675,"derivative":{"exercise_price":3.46,"exercise_date":"2023-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":5675},"source":{"system":"sec-edgar","filing":"0001127602-23-012019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223012019/form4.xml","form_type":"4"}},{"id":1944777,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-20T20:27:36.000Z","date":"2023-03-16","kind":"purchase","planned":false,"acquired":true,"shares":1333,"price":3.64,"value":4852.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $3.55 to $3.70, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":301709.04,"source":{"system":"sec-edgar","filing":"0001127602-23-010853","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223010853/form4.xml","form_type":"4"}},{"id":1957012,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-13T10:27:35.000Z","date":"2023-03-10","kind":"purchase","acquired":true,"shares":443,"price":3.98,"value":1763.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.935 to $4.00, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":300376.04,"source":{"system":"sec-edgar","filing":"0001127602-23-009813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009813/form4.xml","form_type":"4"}},{"id":1957011,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-13T10:27:35.000Z","date":"2023-03-09","kind":"purchase","acquired":true,"shares":1057,"price":3.98,"value":4206.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $3.87 to $4.00, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":299933.04,"source":{"system":"sec-edgar","filing":"0001127602-23-009813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009813/form4.xml","form_type":"4"}},{"id":1963579,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-08T11:37:36.000Z","date":"2023-03-07","kind":"purchase","acquired":true,"shares":871,"price":4.25,"value":3701.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.22 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":298876.04,"source":{"system":"sec-edgar","filing":"0001127602-23-009394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009394/form4.xml","form_type":"4"}},{"id":1963578,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-08T11:37:36.000Z","date":"2023-03-06","kind":"purchase","acquired":true,"shares":481,"price":4.24,"value":2039.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $4.23 to $4.25, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":298005.04,"source":{"system":"sec-edgar","filing":"0001127602-23-009394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009394/form4.xml","form_type":"4"}},{"id":2003924,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-21T11:56:40.000Z","date":"2023-02-17","kind":"purchase","acquired":true,"shares":50,"price":4.25,"value":212.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.24 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":297524.04,"source":{"system":"sec-edgar","filing":"0001127602-23-006045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223006045/form4.xml","form_type":"4"}},{"id":2003923,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-21T11:56:40.000Z","date":"2023-02-16","kind":"purchase","acquired":true,"shares":10,"price":4.25,"value":42.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended."}],"balance_after":297474.04,"source":{"system":"sec-edgar","filing":"0001127602-23-006045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223006045/form4.xml","form_type":"4"}},{"id":2068594,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-01-04T22:49:55.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":3045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 30, 2022 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":3045,"derivative":{"exercise_price":3.51,"exercise_date":"2022-12-30","expiration_date":"2032-12-30","underlying":"Common Stock","underlying_shares":3045},"source":{"system":"sec-edgar","filing":"0001127602-23-000647","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223000647/form4.xml","form_type":"4"}},{"id":2160302,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-13T22:19:53.000Z","date":"2022-09-13","kind":"purchase","acquired":true,"shares":8798.73,"price":3.85,"value":33875.1105,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased by the reporting person in the open market for $3.85 per share on September 13, 2022."}],"balance_after":297464.04,"source":{"system":"sec-edgar","filing":"0001127602-22-022401","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222022401/form4.xml","form_type":"4"}},{"id":2169131,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-01T17:46:06.000Z","date":"2022-08-30","kind":"purchase","acquired":true,"shares":283.31,"price":3.97,"value":1124.7407,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased by the reporting person in the open market for $3.97 per share on August 30, 2022."}],"balance_after":288665.31,"source":{"system":"sec-edgar","filing":"0001127602-22-021869","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222021869/form4.xml","form_type":"4"}},{"id":2197910,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T22:29:11.000Z","date":"2022-08-01","kind":"purchase","acquired":true,"shares":20000,"price":5,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were purchased by the reporting person in the issuer's initial public offering, which closed on August 1, 2022."}],"balance_after":288382,"source":{"system":"sec-edgar","filing":"0000899243-22-027444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000089924322027444/doc4.xml","form_type":"4"}},{"id":2197909,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":18004,"kind":"person","name":"Guerrero Ramiro","position":1,"cik":"0001913253","reported_name":"Guerrero Ramiro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T22:29:11.000Z","date":"2022-07-28","kind":"purchase","acquired":true,"shares":9000,"price":4,"value":36000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased by the reporting person in the open market for $4.00 per share on July 28, 2022."}],"balance_after":268382,"source":{"system":"sec-edgar","filing":"0000899243-22-027444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000089924322027444/doc4.xml","form_type":"4"}}]}